854 filings
Page 4 of 43
4
93uzgf 1pqogh2z
13 Mar 23
INOVIO PHARMACEUTICALS / PETER KIES ownership change
5:06pm
POS AM
jiwc8bg
1 Mar 23
Prospectus update (post-effective amendment)
5:07pm
POSASR
p29bkn5xv5k6t 6e6
1 Mar 23
Automatic shelf registration (post-effective amendment)
4:30pm
8-K
gy35ke3kyz67
1 Mar 23
INOVIO Reports Fourth Quarter and Full Year 2022 Financial
4:20pm
4
ymdy262s5 wk
28 Feb 23
INOVIO PHARMACEUTICALS / Jacqueline Elizabeth Shea ownership change
5:44pm
4
zwp2ry ult
28 Feb 23
INOVIO PHARMACEUTICALS / PETER KIES ownership change
5:42pm
4
flbs45963f sllu
28 Feb 23
INOVIO PHARMACEUTICALS / David B. Weiner ownership change
5:40pm
4
6zgnw3ncy09wovmeml
28 Feb 23
INOVIO PHARMACEUTICALS / Michael John Sumner ownership change
5:38pm
4
bav9m6nef0yqwj6ia3cc
28 Feb 23
INOVIO PHARMACEUTICALS / Laurent Humeau ownership change
12:00am
SC 13G/A
p80 dhtofgkgqpx7ijh
9 Feb 23
INOVIO PHARMACEUTICALS / STATE STREET ownership change
3:11pm
SC 13G/A
cefn2wqyhyi8 c4s
9 Feb 23
INOVIO PHARMACEUTICALS / VANGUARD ownership change
11:22am
8-K
mwwss2lzufjtkm5m
31 Jan 23
Cost Associated with Exit or Disposal Activities
8:12am
SC 13G/A
08hmnh6o708ei7she
24 Jan 23
INOVIO PHARMACEUTICALS / BlackRock ownership change
1:56pm
4
iphlz vddlrh
17 Jan 23
INOVIO PHARMACEUTICALS / Jay Shepard ownership change
4:05pm
8-K
7ochmhqpuim7v0n91 gs
8 Nov 22
INOVIO Reports Financial Results and Highlights for the Third Quarter 2022
4:13pm
UPLOAD
1gvggjeqqj peinn5ysn
14 Oct 22
Letter from SEC
12:00am
CORRESP
f6h14
29 Sep 22
Correspondence with SEC
12:00am
UPLOAD
fr0b 5vf3ax6
15 Sep 22
Letter from SEC
12:00am